Eton Pharmaceuticals, Inc. (ETON): Depreciation & Amortization
$4.04M
Year ended 2025-12-31
$4.54M
Trailing 12 months to 2026-06-30
+31.6%
3-year compound annual growth
+44.1%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.04M | +252.9% | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | $1.15M | +27.2% | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | $901.0K | -49.2% | 2026-03-19, From 2023-01-01 |
| 2022-12-31 | $1.77M | +284.0% | 2025-03-18, From 2022-01-01 |
| 2021-12-31 | $462.0K | -29.0% | 2024-03-14, From 2021-01-01 |
| 2020-12-31 | $651.0K | +45.6% | 2023-03-16, From 2020-01-01 |
| 2019-12-31 | $447.0K | +609.5% | 2022-03-16, From 2019-01-01 |
| 2018-12-31 | $63.0K | n/a | 2021-03-16, From 2018-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $4.04M | +252.9% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $3.02M | -14.6% |
| Nurix Therapeutics, Inc. (NRIX) | 2025-11-30 | $8.74M | -6.2% |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | $1.37M | n/m |
| Standard Biotools Inc. (LAB) | 2025-12-31 | $9.26M | -26.0% |
| Cytokinetics Inc (CYTK) | 2025-12-31 | $10.12M | +6.2% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $6.42M | -10.5% |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | $129.0K | 0.0% |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | $460.0K | -14.8% |
Compare ETON, ARCT, NRIX, SPRY side by side · Screen every company in Pharmaceutical Preparations ↗